Susquehanna Portfolio Strategies, LLC

Position in VNDA — Vanda Pharmaceuticals Inc.

CIK 1996449 Bala Cynwyd, PA

Position in VNDA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,451,566

-$359,614 QoQ

Shares Held

237,184

-9.5% QoQ

Ownership

0.392%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#33

of 172 holders

Holding Since

Dec 2023

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Susquehanna Portfolio Strategies, LLC holds $399,265,861 across 121 Biotechnology names. VNDA ranks #55 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	90,928	$45,166,665
2	MRNA	Moderna, Inc.	471,043	$32,987,141
3	CORT	Corcept Therapeutics Inc	211,017	$18,347,928
4	BBIO	BridgeBio Pharma, Inc.	226,869	$16,897,203
5	BMRN	Biomarin Pharmaceutical Inc	273,562	$15,653,217
6	HALO	Halozyme Therapeutics, Inc.	166,503	$13,032,189
7	EXEL	Exelixis, Inc.	229,749	$12,500,643
8	MDGL	Madrigal Pharmaceuticals, Inc.	22,003	$11,814,510

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,451,566	237,184	-9.5%	Shares	Sole	2026-08-14
2026-03-31	$1,811,180	262,110	+74.2%	Shares	Sole	2026-05-15
2025-12-31	$1,326,766	150,427	+35.1%	Shares	Sole	2026-02-17
2025-09-30	$555,586	111,340	+14.7%	Shares	Sole	2025-11-14
2025-06-30	$458,118	97,059	+84.7%	Shares	Sole	2025-08-14
2024-09-30	$246,445	52,547	0.0%	Shares	Defined	2024-11-14
2024-06-30	$296,890	52,547	0.0%	Shares	Defined	2024-08-15
2024-03-31	$215,968	52,547	-65.5%	Shares	Defined	2024-05-07
2023-12-31	$643,334	152,449	—	Shares	Defined	2024-02-14
No filing history on record for this holder in this stock.